Cystatin SN promotes epithelial-mesenchymal transition and serves as a prognostic biomarker in lung adenocarcinoma. Yang J, Luo G, Li C, Zhao Z, et al. BMC Cancer 2022;22:589.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yang J, Luo G, Li C, Zhao Z, et al. Cystatin SN promotes epithelial-mesenchymal transition and serves as a prognostic biomarker in lung adenocarcinoma. BMC Cancer 2022;22:589.
PMID: 35637432